Download Free Sample Report

The global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market was valued at US$ 7.97 billion in 2023 and is projected to reach US$ 8.11 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Pacemaker is a medical device that uses electric shocks to continuously and regularly stimulate the heart muscles to maintain the continuous beating of the heart. Implantable cardioverter defibrillators or automatic implantable cardioverter defibrillators are devices that can be implanted in the body and can perform cardioversion, defibrillation and pacing of the heart. Therefore, the device can correct most life-threatening arrhythmias. For patients at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia, ICD is the first-line treatment and preventive treatment.
This report aims to provide a comprehensive presentation of the global market for Pacemakers and Implantable Cardioverter Defibrillators (ICDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pacemakers and Implantable Cardioverter Defibrillators (ICDs). This report contains market size and forecasts of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in global, including the following market information:

• Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Pacemakers and Implantable Cardioverter Defibrillators (ICDs) companies in 2023 (%)

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Pacemakers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) include Medtronic Inc., Boston Scientific, ZOLL Medical Corp., Asahi Kasei Corp., Nihon Kohden Corp., Shree Pacetronix Ltd., St. Jude Medical, Inc, BIOTRONIK SE & Co. KG and EBR Systems, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Segment Percentages, by Type, 2023 (%)

• Pacemakers
• Implantable Cardioverter Defibrillators

Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Segment Percentages, by Application, 2023 (%)

• Hospitals
• Speciality Clinics & Cardiac Centres
• Ambulatory centres
• Others

Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Pacemakers and Implantable Cardioverter Defibrillators (ICDs) revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Pacemakers and Implantable Cardioverter Defibrillators (ICDs) revenues share in global market, 2023 (%)
• Key companies Pacemakers and Implantable Cardioverter Defibrillators (ICDs) sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Pacemakers and Implantable Cardioverter Defibrillators (ICDs) sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic Inc.
• Boston Scientific
• ZOLL Medical Corp.
• Asahi Kasei Corp.
• Nihon Kohden Corp.
• Shree Pacetronix Ltd.
• St. Jude Medical, Inc
• BIOTRONIK SE & Co. KG
• EBR Systems, Inc.
• MEDICO S.p.A.
• Osypka Medical GmbH
• Physio-Control Corp.

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Pacemakers and Implantable Cardioverter Defibrillators (ICDs), market overview.
• Chapter 2: Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size in revenue and volume.
• Chapter 3: Detailed analysis of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.